Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer

Clinical trial NCT01729481 · UNKNOWN

Trial details

NCT number: NCT01729481
Sponsor: Ludwig-Maximilians - University of Munich
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Adenocarcinoma

Start date: 2012-07-01
Primary completion: 2015-07-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.